MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Histone Deacetylase Inhibitors Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

686 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
686 works in the cohort · of 4,299,418page 1 of 14

Labels cover 1 of 686 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 686 of 686 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundno abstractunlabeled
Epigenetic protein families: a new frontier for drug discovery
C.H. Arrowsmith, C. Bountra, Paul V. Fish, Kevin Lee, Matthieu Schapira
2012· review· en· Nature Reviews Drug Discovery· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · metaepi_narrow
1,308
citations
affno abstractunlabeled
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon, Meral Beksaç, Meletios Α. Dimopoulos, Ashraf Elghandour +39 more
2014· article· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
788
citations
afffundno abstractunlabeled
MYST-family histone acetyltransferases: beyond chromatin
Vasileia Sapountzi, Jacques Côté
2010· review· en· Cellular and Molecular Life Sciences· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
207
citations

How this was built: Screen · Findings · About